SCHEMBL30009723

SCHEMBL30009723

O=C(O)c1cc(Br)c2ccn(-c3ccccc3)c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.44
RHEB Q15382 1/20 0.43
TTR P02766 1/20 0.41
NOTUM Q6P988 1/20 0.41
PLA2G4A P47712 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39
KDM4E B2RXH2 3/20 0.38
P2RX3 P56373 2/20 0.38
P2RX2 Q9UBL9 2/20 0.38
RORC P51449 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23217889 1.00 FGFR1 (0.44) FGFR1RHEBTTRNOTUMPLA2G4A
SCHEMBL30010282 0.85 FGFR1 (0.47) FGFR1NOTUMKDM4EP2RX3P2RX2
SCHEMBL21439171 0.85 FGFR1 (0.47) FGFR1NOTUMKDM4EP2RX3P2RX2
SCHEMBL732887 0.78 CA12 (0.45) FGFR1TTRNOTUMKDM4EPKM
SCHEMBL29856013 0.76 TTR (0.44) RHEBTTRKDM4E
SCHEMBL19100569 0.76 TTR (0.44) RHEBTTRKDM4E
SCHEMBL21439140 0.76 RHEB (0.35) FGFR1RHEBNOTUMPLA2G4AHDAC3
SCHEMBL21439305 0.75 RHEB (0.67) RHEBNOTUMHDAC3HDAC4HDAC1
SCHEMBL24950460 0.73 FGFR1 (0.55) FGFR1NOTUMPLA2G4AHDAC3HDAC4
SCHEMBL30201454 0.73 FGFR1 (0.55) FGFR1NOTUMPLA2G4AHDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4041717-A1 ORAL COMPLEMENT FACTOR D INHIBITORS Biocryst Pharmaceuticals, Inc. (US) 2022-08-17 EP disclosed